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It is necessary to develop methods for accurate monitoring of cell-free hemoglobin in circulation. Routine monitoring of circulating cell-free hemoglobin will be useful for evaluating the efficacy of blood substitute administration and for determining the clearance rates of the blood substitute from circulation. In addition, discriminating between cell-free hemoglobin and cell-associated hemoglobin will enable accurate determination of RBC indices, mean cell hemoglobin and mean corpuscular hemoglobin concentration, in individuals receiving hemoglobinbased blood substitutes. As colorimetric methods used by hematology analyzers to quantitate the hemoglobin value of a blood sample cannot distinguish between cell-associated and cell-free hemoglobin, it is currently not feasible to quantitate the levels of hemoglobin substitutes in circulation. The advent of a technology that measures volume and hemoglobin concentration of individual RBCs provides an alternative strategy for quantitating the cell-associated hemoglobin in a blood sample. We document that the combined use of cellbased and colorimetric hemoglobin measurements provides accurate discrimination between cellassociated and cell-free hemoglobin over a wide range of hemoglobin levels. This strategy should enable rapid and accurate monitoring of the levels of cell-free hemoglobin substitutes in the circulation of recipients of these blood substitutes.
Substantial progress is being made in the development of safe and effective hemoglobin-based blood substitutes. [1] [2] [3] [4] [5] [6] A number of these hemoglobin-based blood substitutes are in phase 3 clinical trials for the treatment of patients with acute blood loss following severe trauma. At present there is no automated method to quantitate the circulating levels of hemoglobin-based blood substitutes in a blood sample. As the approval of these blood substitutes for clinical use is imminent, we embarked on developing an automated method to monitor the levels of hemoglobin substitutes in the circulation of recipients of these blood products.
The hemoglobin value, a principal component of the CBC count, is determined by automated hematology analyzers using colorimetric methods. 7 These colorimetric methods measure total hemoglobin (Hgb total , in g/dL), which includes both cell-associated hemoglobin (Hgb cell ) and cell-free hemoglobin (Hgb free ). With the advent of a technology that simultaneously measures the volume (V, fL) and the hemoglobin concentration (HC, g/dL) of individual RBCs, it is possible to obtain an independent measure of Hgb cell as Hgb cell = RBC × MCV × CHCM, where RBC is the RBC count, MCV is mean cell volume, and CHCM (equivalent to mean corpuscular hemoglobin concentration [MCHC] ) is the mean cellular hemoglobin concentration. In the present study, we first validated the accuracy of this cell-by-cell approach of quantitating hemoglobin levels in samples without cell-free hemoglobin by comparing Hgb cell with Hgb total values derived by colorimetric determination on blood samples. Based on measurements performed on 186 normal blood samples and 1,701 patient blood samples, we demonstrated that Hgb cell accurately reflects the circulating cell-associated hemoglobin values in these samples.
As the cell-based method quantitates only hemoglobin in RBCs (Hgb cell ), while colorimetric determination of the hemoglobin level (Hgb total ) reflects both hemoglobin in RBCs (Hgb cell ) and hemoglobin in plasma (Hgb free ), we surmised that the combined use of these 2 measurements should enable us to accurately measure cell-free hemoglobin in blood samples. By using mixtures of whole blood and 3 different hemoglobin-based blood substitutes, we were able to document that our experimental strategy can accurately quantitate the levels of hemoglobin substitutes (Hgb free ) in the circulation of recipients of these blood products.
Materials and Methods
Blood Samples
Fresh K 3 -EDTA-anticoagulated blood samples from 186 healthy volunteers and 1,701 patients were evaluated. All blood samples were analyzed within 4 hours of phlebotomy. Patient blood samples were from individuals with RBC disorders such as iron deficiency, thalassemia, and sickle cell disease.
Blood Substitutes
A hemoglobin-based blood substitute, PEG hemoglobin at a concentration of 5.4 g/dL (54 g/L), was obtained from Enzon (Piscataway, NJ). Hemopure (HBOC-201) and Oxyglobin blood substitutes at a concentration of 13 g/dL (130 g/L) were obtained from Biopure (Cambridge, MA). Varying proportions of blood substitute solutions and normal blood were mixed to a final volume of 5 mL to produce samples with a range of cellular and cell-free hemoglobin concentrations.
The 2-Dimensional RBC Analysis Method
Two-dimensional RBC analysis is an optical method in which both volume and refractive index of isotonically sphered RBCs are determined simultaneously on a cell-bycell basis by measuring 2 angles of laser light scatter. [8] [9] [10] The 2 scatter measurements are converted into volume and refractive index values using the Mie theory of light scattering for homogeneous spheres. The refractive index values subsequently are converted into cellular hemoglobin concentration values. This method is the basis for RBC analysis on the ADVIA 120 Hematology System (Bayer, Tarrytown, NY).
The RBC scatter cytogram ❚Figure 1❚ is a graphic representation of 2 light scatter measurements: high-angle (5°-15°) light scatter events are plotted along the x-axis and low-angle (2°-3°) light scatter events along the y-axis. The RBC scatter/scatter cytogram map resolves volumes 
Statistical Analysis
The acquired data were analyzed statistically using Excel 7.0 for Microsoft Windows 95 (Microsoft, Redmond, WA). The parameters derived included calculations of mean values, SD, and linear regression analysis with correlation coefficient, slope, and intercept.
Results
Blood Hemoglobin Levels
By using the automated ADVIA 120 Hematology System, the cellular hemoglobin values of blood samples (Hgb cell ) were compared with hemoglobin values derived by colorimetric determination on blood samples lysed by the hemoglobin reagent (Hgb total ). As shown in ❚Figure 2❚, there is an excellent correlation between hemoglobin values derived from measured RBC indices (Hgb cell ) and colorimetric hemoglobin measurement (Hgb total ). For 186 normal blood samples, the correlation coefficient (r 2 ) was 0.9611, and the slope of the regression line was 1.00 with an intercept of -0.06 ❚Figure 2A❚. For 1,701 patient blood samples, the correlation coefficient (r 2 ) was 0.9767, and the slope of the regression line was 0.97 with an intercept of 0.32 ❚Figure 2B❚. Thus, cellular hemoglobin measurement (Hgb cell ) accurately reflects the cell-associated hemoglobin values of all blood samples. Three different hemoglobin measurement values are reported by the ADVIA 120 Hematology System: Hgb total reflecting both cell-associated and cell-free hemoglobin determined colorimetrically is reported as "HGB"; Hgb cell reflecting only the cell-associated hemoglobin is reported as "Calculated HGB"; and the difference between these 2 hemoglobin values, reflecting cell-free hemoglobin, is reported as "HGB Delta." All 3 hemoglobin values appear on the display screen on the completion of the 30-second analytic cycle that follows the aspiration of the blood sample.
Hemoglobin Content of RBCs
The mean CH of RBCs in the blood sample was derived using the data set from a dual measurement of V and HC of individual red cells, as shown in Figure 1 . The mean cell hemoglobin content (MCH) also can be derived from 2 other independent measurements, namely hemoglobin concentration and RBC count (MCH = Hgb/RBC). To verify that the CH value derived from measured volume and cell hemoglobin concentration values is equivalent to MCH derived Figure 3B ). The mean values were as follows: MCH, 28.9 pg; and CH, 28.7 pg. Thus, the CH value was equivalent to MCH for samples without extracellular hemoglobin.
Quantitation of Cell-Free Hemoglobin From Blood Substitutes
Since the cell-based method quantitates only cellular hemoglobin (Hgb cell ), while the colorimetric method (Hgb total ) quantitates the sum of both cellular and cell-free hemoglobin, we explored whether the combined use of these 2 measurements would enable the accurate quantitation of hemoglobin blood substitutes (Hgb free ) in a blood sample. A value for Hgb free is derived as the difference between Hgb total and Hgb cell. Blood samples with varying amounts of cellular and cell-free hemoglobin were prepared by mixing appropriate amounts of the hemoglobin-based blood substitute PEG hemoglobin, at a concentration of 5.4 g/dL (54 g/L), with normal blood (diluted to a hemoglobin concentration of 5.6 g/dL (56 g/L) and analyzed. As shown in ❚Figure 4❚, the combined use of Hgb cell and Hgb total enabled accurate discrimination between cellular and cell-free hemoglobin over a wide range of hemoglobin substitute levels (0. ❚Figure 5❚ Accurate measurement of cell-associated and cellfree hemoglobin in mixtures of normal blood and the blood substitute Oxyglobin (Biopure, Cambridge, MA). Linear regression analysis of assayed (symbols) and predicted (solid line) cell-associated and cell-free hemoglobin from the hemoglobin substitute Oxyglobin in blood samples. The correlation coefficients (r 2 ) between assayed and predicted values for cell-associated and cell-free hemoglobin were 0.999 and 0.999, respectively. The slope of the regression line and the intercept were 1.00 and 0.07 for cell-associated hemoglobin and 1.00 and -0.13 for cell-free hemoglobin. Data also are given in tabular form (Table 2) . Values are given in conventional units; to convert to Système International units (grams per liter), multiply by 10. Triangles, cellassociated hemoglobin; circles, cell-free hemoglobin.
❚Figure 6❚ Accurate measurement of cell-associated and cellfree hemoglobin in mixtures of normal blood and the blood substitute Hemopure (Biopure, Cambridge, MA). Linear regression analysis of assayed (symbols) and predicted (solid line) cell-associated and cell-free hemoglobin from the hemoglobin substitute Hemopure in blood samples. The correlation coefficients (r 2 ) between assayed and predicted values for cell-associated and cell-free hemoglobin were 0.999 and 0.999, respectively. The slope of the regression line and the intercept were 0.99 and 0.05 for cell-associated hemoglobin and 0.995 and -0.03 for cell-free hemoglobin. Data also are given in tabular form (Table 3) . Values are given in conventional units; to convert to Système International units (grams per liter), multiply by 10. Triangles, cellassociated hemoglobin; circles, cell-free hemoglobin.
Discussion
The circulating hemoglobin value that is used routinely for assessing the degree of anemia in individual patients has long been quantitated using colorimetric methods. These colorimetric methods quantitate total hemoglobin, which includes both cell-associated and cell-free hemoglobin in plasma. The advent of technology that enables the measurement of V and HC of individual RBCs for the first time provides a cell-based strategy for quantitating exclusively cell-associated hemoglobin in a blood sample. In the present study, we documented the accuracy of this new RBC-based approach for quantitating cell-associated hemoglobin levels. Based on measurements performed on 186 normal blood samples and 1,701 patient blood samples, we showed that the cell-by-cell approach can accurately measure circulating hemoglobin values. The concordance between hemoglobin values determined by the new method and those derived by the well-established colorimetric method is excellent.
More important, through the combined use of the cell-by-cell and colorimetric hemoglobin measurements, we effectively discriminated between cellular and cellfree hemoglobin over a wide range of hemoglobin levels. The range of admixed hemoglobin substitutes tested (0-13 g/dL [0-130 g/L]) should cover the entire range of attainable levels of these products in recipients. As there are no automated methods to discriminate between cell-associated and cell-free hemoglobin in a blood sample, the novel strategy outlined herein to discriminate between these 2 sources of hemoglobin should be particularly useful for monitoring the levels of hemoglobin-based blood substitutes in the circulation of recipients of these blood products.
Another advantage of the experimental strategy we have outlined is that it will enable the accurate determination of RBC MCH and MCHC values in blood samples of recipients of hemoglobin-based blood substitutes. As the RBC MCH and MCHC values should reflect only cell-associated hemoglobin, the hematology analyzers that fail to discriminate between cell-associated and cellfree hemoglobin values will markedly overestimate the values for MCH and MCHC by failing to exclude the contribution of cell-free hemoglobin to the derived MCH and MCHC values. For example, in a blood sample from a transfusion recipient with an RBC count of 3.33 × 10 6 /µL (3.33 × 10 12 /L), an MCV of 90 µm 3 (90 fL), and a total hemoglobin value of 15 g/dL (150 g/L) composed of 10 g/dL (100 g/L) of RBC-associated hemoglobin and 5 g/dL (50 g/L) of hemoglobin-based blood substitute, the MCHC and MCH values for RBCs will be erroneously reported by standard hematology analyzers as 50.5 g/dL (505 g/L) and 45.0 pg respectively, instead of the correct values of 33.7 g/dL (337 g/L) and 30 pg, owing to their failure to discount the contribution of cell-free hemoglobin to the derived values. In contrast, the experimental strategy we have outlined, through its ability to discriminate between cell-associated and cell-free hemoglobin, will derive accurate values for MCHC and MCH for such a blood sample.
As it is likely that during the coming years hemoglobinbased blood substitutes will be used in clinical practice, the experimental strategy we have described should have significant practical application in transfusion medicine.
